Does the pattern seen after photocoagulation (laser treatment) when blinking inevitably mean scotomas (blind spots) or could it be just afterimages without actual blind spots?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Patterns After Photocoagulation: Afterimages vs. Scotomas

The patterns seen after photocoagulation when blinking are not inevitably scotomas; they can be temporary afterimages without permanent blind spots, but the risk of developing actual scotomas depends on the treatment location, energy levels used, and proximity to critical visual structures. 1

Understanding Photocoagulation Effects

Temporary vs. Permanent Visual Phenomena

  • Afterimages: Normal temporary visual phenomena that fade with time
  • Scotomas: Permanent blind spots in the visual field resulting from tissue damage

Factors Determining Scotoma Formation

Treatment Location

  • High Risk Areas:
    • Near the central macula or fovea
    • Within 500 μm of the center of the macula 2
    • Near the optic nerve

Laser Parameters

  • Energy Level: Higher energy increases risk of thermal damage to adjacent tissues 1
  • Wavelength: Argon laser (448-514.5 nm) carries specific risk profiles 1
  • Duration: Longer pulse durations may increase tissue damage

Evidence-Based Risk Assessment

Conventional Photocoagulation

  • Conventional photocoagulation for conditions like diabetic macular edema can cause permanent paracentral scotomas 2
  • Focal laser photocoagulation surgery may rarely induce subretinal fibrosis with choroidal neovascularization, potentially causing permanent central vision loss 2

Modified Techniques with Lower Risk

  • Subthreshold Techniques:
    • Subthreshold diode micropulse photocoagulation for central serous chorioretinopathy showed no post-treatment subjective complaints of increased paracentral scotomas 3
    • Subthreshold (invisible) diode laser modified grid photocoagulation appears to reduce both objective and subjective effects on the paracentral visual field 4

Clinical Considerations

Risk Mitigation Strategies

  • Use minimum effective energy levels 1
  • Consider alternative treatments like photodynamic therapy (PDT) when appropriate 2, 1
  • Avoid foveal vasculature within at least 500 μm of the center of the macula 2

Patient Perception Factors

  • The filling-in phenomenon may mask scotomas, especially in patients with bilateral central scotomas 5, 6
  • This perceptual filling-in occurs most frequently (85%) in the less severely affected eye of patients with bilateral central scotoma 5

Important Caveats

  • Photocoagulation does not clearly address underlying choroidal leakage and carries the risk of inducing choroidal neovascularization and symptomatic paracentral scotoma 2
  • The perception of scotomas may be influenced by the brain's ability to "fill in" missing information, making some scotomas less noticeable to patients 6
  • Patients with better vision in their fellow eye may be more likely to notice scotomas in the treated eye 5

Follow-up Recommendations

  • Schedule post-treatment evaluation within 3-4 months of laser surgery 2
  • Test for the presence of laser-related scotomas with Amsler grid screening 3
  • Monitor for any signs of choroidal neovascularization, which may develop as a complication of photocoagulation 2

References

Guideline

Argon Laser Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Filling-in phenomenon in patients with age-related macular degeneration: differences regarding uni- or bilaterality of central scotoma.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.